U.S., March 22 -- ClinicalTrials.gov registry received information related to the study (NCT06890078) titled 'Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients' on March 17.
Brief Summary: Evaluate new diagnostic methods using qPCR on non-invasive samples, compared with reference techniques for the positive diagnosis of pneumocystis (PcP) in immunocompromised patients
Study Start Date: April 15
Study Type: OBSERVATIONAL
Condition:
Pneumocystis
Immunocompromised Patients
Intervention:
OTHER: Biological sampling
Mouthwash, nasopharyngeal swab, blood sampling
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Assistance Publique - Hopitaux de Paris
Published by HT Digital Content Services with permission from Healt...